Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juxiang Chen

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Journal of Translational Medicine|October 12, 2014
Expression and prognostic significance of TCTN1 in human glioblastomaDelong Meng, Yuanyuan Chen, Yingjie Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2017
Hippo signaling promotes JNK-dependent cell migrationXianjue Ma, Hongxiang Wang, Jiansong Ji, et al.
American Journal of Cancer Research|March 25, 2017
The E3 ubiquitin ligase CHIP/miR-92b/PTEN regulatory network contributes to tumorigenesis of glioblastomaTao Xu, Hongxiang Wang, Mei Jiang, et al.
Materials Today. Bio|January 27, 2025
Brain-targeting drug delivery systems: The state of the art in treatment of glioblastomaBo Sun, Rong Li, Ning Ji, et al.
The Journal of Gene Medicine|February 18, 2025
Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO-1 PathwaysJinxiang Huang, Qixuan Li, Hongxiang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2024
Dysregulated inter-mitochondrial crosstalk in glioblastoma cells revealed by in situ cryo-electron tomographyRui Wang, Huan Lei, Hongxiang Wang, et al.
Brain Research|June 30, 2009
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiformeYiming Li, Weiqing Li, Yongji Yang, et al.
Redox Biology|June 5, 2024
A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastomaZong Miao, Lei Xu, Wei Gu, et al.
International Journal of Oncology|July 20, 2022
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, et al.
Acta Neuropathologica Communications|January 24, 2026
Deficiency of SMARCB1 drives an immunosuppressive microenvironment in meningiomaBen Jin, Hao Hu, Yanhua Lu, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Journal of Translational Medicine|October 12, 2014
Expression and prognostic significance of TCTN1 in human glioblastomaDelong Meng, Yuanyuan Chen, Yingjie Zhao, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2017
Hippo signaling promotes JNK-dependent cell migrationXianjue Ma, Hongxiang Wang, Jiansong Ji, et al.
American Journal of Cancer Research|March 25, 2017
The E3 ubiquitin ligase CHIP/miR-92b/PTEN regulatory network contributes to tumorigenesis of glioblastomaTao Xu, Hongxiang Wang, Mei Jiang, et al.
Materials Today. Bio|January 27, 2025
Brain-targeting drug delivery systems: The state of the art in treatment of glioblastomaBo Sun, Rong Li, Ning Ji, et al.
The Journal of Gene Medicine|February 18, 2025
Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO-1 PathwaysJinxiang Huang, Qixuan Li, Hongxiang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2024
Dysregulated inter-mitochondrial crosstalk in glioblastoma cells revealed by in situ cryo-electron tomographyRui Wang, Huan Lei, Hongxiang Wang, et al.
Brain Research|June 30, 2009
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiformeYiming Li, Weiqing Li, Yongji Yang, et al.
Redox Biology|June 5, 2024
A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastomaZong Miao, Lei Xu, Wei Gu, et al.
International Journal of Oncology|July 20, 2022
Glioma‑neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)Tianzhen Hua, Huanxiao Shi, Mengmei Zhu, et al.
Acta Neuropathologica Communications|January 24, 2026
Deficiency of SMARCB1 drives an immunosuppressive microenvironment in meningiomaBen Jin, Hao Hu, Yanhua Lu, et al.
Pageof 12